Shimada, I; Maeno, K; Kazuta, K; Kubota, H; Kimizuka, T; Kimura, Y; Hatanaka, K; Naitou, Y; Wanibuchi, F; Sakamoto, S; Tsukamoto, S. Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists. Bioorg. Med. Chem., 15 Feb 2008, 16 (4), 1966–1982. 301 kB. https://doi.org/10.1016/j.bmc.2007.10.100
5-MeO-pyr-T · 5-Methoxy-pyr-tryptamine
4-HO-pip-T · 4-Hydroxy-pip-tryptamine
4,5-DHP-DMT · 4,5-Dihydropyrano-N,N-dimethyltryptamine
5,6-DHP-DMT · 5,6-Dihydropyrano-N,N-dimethyltryptamine
5-MeO-MALT · 5-Methoxy-N-methyl-N-allyltryptamine
5-Cyclopentyloxy-T · 5-Cyclopentyloxytryptamine
1-Methyl-4,5-DHP-AMT · 1-Methyl-4,5-dihydropyrano-α-methyltryptamine
4-HO-EALT · 4-Hydroxy-N-ethyl-N-allyltryptamine
4-HO-N-cyclopropylmethyl-NMT · 4-Hydroxy-N-cyclopropylmethyl-N-methyltryptamine
4-HO-ECPT · 4-Hydroxy-N-ethyl-N-cyclopropyltryptamine
4-HO-MCBT · 4-Hydroxy-N-methyl-N-cyclobutyltryptamine
5-Propanoyl-N,N-dimethyltryptamine · 5-Propanoyl-DMT · 5-Propionyl-DMT
6,7-DHP-3,α-dimethyl-iso-DMT · 6,7-Dihydropyrano-3,α-dimethyl-N,N-dimethyl-isotryptamine
5-MeO-MCPT · 5-Methoxy-N-methyl-N-cyclopropyltryptamine